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Cerebral blood ﬂow response to acute
hypoxic hypoxia
Ashley D. Harrisa, Kevin Murphya, Claris M. Diaza, Neeraj Saxenab,
Judith E. Hallb, Thomas T. Liuc and Richard G. Wisea*
Hypoxic hypoxia (inspiratory hypoxia) stimulates an increase in cerebral blood ﬂow (CBF) maintaining oxygen delivery
to the brain. However, this response, particularly at the tissue level, is not well characterised. This study quantiﬁes the
CBF response to acute hypoxic hypoxia in healthy subjects. A 20-min hypoxic (mean PETO2 =52 mmHg) challenge was
induced and controlled by dynamic end-tidal forcing whilst CBF was measured using pulsed arterial spin labelling
perfusion MRI. The rate constant, temporal delay and magnitude of the CBF response were characterised using an
exponential model for whole-brain and regional grey matter. Grey matter CBF increased from 76.1 mL/100 g/min
(95% conﬁdence interval (CI) of ﬁtting: 75.5 mL/100 g/min, 76.7 mL/100 g/min) to 87.8 mL/100 g/min (95% CI:
86.7 mL/100 g/min, 89.6 mL/100 g/min) during hypoxia, and the temporal delay and rate constant for the
response to hypoxia were 185 s (95% CI: 132 s, 230 s) and 0.0035 s–1 (95% CI: 0.0019 s–1, 0.0046 s–1), respectively.
Recovery from hypoxia was faster with a delay of 20 s (95% CI: –38 s, 38 s) and a rate constant of 0.0069 s–1 (95% CI:
0.0020 s–1, 0.0103 s–1). R2*, an index of blood oxygenation obtained simultaneously with the CBF measurement,
increased from 30.33 s–1 (CI: 30.31 s–1, 30.34 s–1) to 31.48 s–1 (CI: 31.47 s–1, 31.49 s–1) with hypoxia. The delay and rate
constant for changes in R2* were 24 s (95% CI: 21 s, 26 s) and 0.0392 s
–1 (95% CI: 0.0333 s–1, 0.045 s–1 ), respectively, for
the hypoxic response, and 12 s (95% CI: 10 s, 13 s) and 0.0921 s–1 (95% CI: 0.0744 s–1, 0.1098 s–1/) during the return to
normoxia, conﬁrming rapid changes in blood oxygenation with the end-tidal forcing system. CBF and R2* reactivity
to hypoxia differed between subjects, but only R2* reactivity to hypoxia differed signiﬁcantly between brain regions.
© 2013 The Authors. NMR in Biomedicine published by John Wiley & Sons, Ltd.
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INTRODUCTION
An acute decrease in the arterial partial pressure of oxygen (PaO2)
stimulates increased blood ﬂow to the brain to maintain cerebral
oxygen delivery. However, the regional perfusion increase can
be subtle during mild hypoxia [arterial PO2 range of 60–150
mmHg (1)], only becoming more pronounced and consistent
with moderate to severe hypoxic challenges (2). The blood ﬂow
response to hypoxia is also dynamic as it evolves with prolonged
hypoxic exposure, for example, over the course of days (1,3).
One of the ﬁrst methods tomeasure blood ﬂow to the brain was
the Kety–Schmidt method, which is based on indicator diffusion
theory (4). It was used to investigate the effects of altered blood
gases on blood ﬂow to the brain (5) and found that blood ﬂow
increased by 35%with a 10% inspired oxygen challenge. Currently,
one of the most widely used techniques for the assessment of
alterations in bulk blood ﬂow is transcranial Doppler (TCD) ultra-
sound. TCD measures velocity directly and relies on the relation-
ship between the arterial blood velocity and blood ﬂow, and
typically assumes a constant vessel cross-sectional area. The blood
ﬂow response to a range of levels of acute and chronic hypoxia, as
well as the sensitivity of blood ﬂow to hypoxic hypoxia at different
levels of end-tidal CO2, have been characterized using TCD ultra-
sound (1,3,6). Reactivity to hypoxia and hypercapnia of different
arteries feeding the brain, speciﬁcally the internal carotids, the
vertebral arteries and the middle (MCA) and posterior cerebral
arteries, has been characterised using TCD (7). The temporal
dynamics of bulk blood ﬂow in the MCA during acute hypoxic
hypoxia have been characterised with TCD, suggesting that
the time constant in response to hypoxia is approximately 80 s
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and the time constant for return to normoxia after hypoxia is 29
s with a delay in the initiation of each response of 5 s (8).
In contrast with the measurement of bulk arterial ﬂow,
cerebral tissue perfusion can be measured using nuclear imaging
methods (positron emission tomography or single photon emis-
sion computed tomography), computed tomography as well as
MR-based methods. With a 12% inspired oxygen challenge,
global cerebral blood ﬂow (CBF) has been shown to increase
by 8.7% (9). CBF in some brain regions has been shown to bemore
responsive to hypoxia than in others (10,11). Binks et al. (11) pro-
vided evidence that phylogenetically older regions of the brain,
such as the basal ganglia, putamen, caudate and pallidum, have
a relatively larger CBF increase in response to hypoxia than ‘newer’
brain regions. Pagani et al. (10) found a different set of regions with
comparatively greater CBF in response to hypoxia, speciﬁcally the
anterior cingulate cortex, right temporal lobe, sensory motor
cortices, prefrontal cortex and the basal ganglia. Regional differ-
ences in the sensitivity of the CBF response to hypoxia may have
implications for regional susceptibility to damage or adaptation
to hypoxic conditions. As an alternative imaging technique, arterial
spin labelling (ASL) MRI provides a method to investigate CBF that
does not require the injection of an exogenous intravascular
contrast agent. In addition, ASL can be performed continuously
and is therefore suitable for the characterisation of the temporal
parameters of the CBF response to hypoxia.
A couple of ASL-based MRI studies have estimated the magni-
tude of the CBF response to hypoxic hypoxia. In one study (12),
the hypoxic challenge was deﬁned by a 9–14% decrease in
blood oxygen saturation, with imaging performed after the
end-tidal oxygen levels had stabilized for several minutes;
however, variable CBF responses were observed. Although there
was a statistically signiﬁcant increase in CBF (7% increase in CBF
per 10% drop in arterial oxygen saturation), 30% of the subjects
showed a negative response, speciﬁcally a drop in CBF with
hypoxia. In an examination of the CBF response to investigate
acute mountain sickness susceptibility (13), CBF was shown to
increase by 11–16% in grey matter during a 30-min ﬁxed
12.5% inspired O2 challenge. Although, in this study, an explicit
description of the temporal CBF response to acute hypoxia was
not given, it appears that the increase in CBF took longer than
the relatively rapid response (less than 2 min) described by
Poulin et al. (8) using TCD.
The objective of this study was to quantify the magnitude and
temporal dynamics of the CBF response to hypoxic hypoxia for
whole-brain grey matter and on a regional basis. R2*, being
sensitive to blood deoxyhaemoglobin content and therefore a
marker of local blood oxygenation (14), was quantiﬁed to
examine the relationship between altered blood oxygenation
and CBF. We measured CBF (using ASL) continuously during a
33-min protocol that included rest, a 20-min inspiratory hypoxic
challenge and a normoxic recovery phase in healthy volunteers.
MATERIALS AND METHODS
Twelve healthy subjects (four men, eight women; 28.6 ± 5.0
years) were recruited for this study. The local ethics committee
approved the study and all subjects gave informed written
consent. All subjects were healthy without vascular, respiratory,
cardiac or neurological disease (self-reported). Each subject was
familiarized with the respiratory circuit outside the MR scanner
prior to the experimental session. An anaesthetist monitored
subjects (peripheral oxygen saturation, respiratory rate and heart
rate) during the hypoxic challenges.
Perfusion measurements
MRI data were collected at 3 T (HDx, General Electric) using an
eight-channel receive-only head coil. CBF was estimated using
a dual-echo, single-shot, proximal inversion with a control for
off-resonance effects – quantitative imaging of perfusion using
single subtraction II (PICORE-QUIPSS II) (15) ASL acquisition with
gradient-echo spiral readout. Imaging parameters were: TR/TE1/
TE2 = 2200 ms/3 ms/29 ms; TI1/TI2 = 600 ms/1500 ms; ﬁeld of
view, 22 cm×22 cm; six slices, 7 mm thick, with a 1-mm gap
between slices; matrix, 64 × 64. A 33-min scan (900 repetitions)
was performed during the hypoxia protocol (described below).
Slices were placed to maximize coverage of the cerebrum with
the most inferior slice at the base of the occipital lobe and
extending superiorly to include the parietal and temporal
lobes.
CBF data were pre-processed using surround subtraction of
the ASL tag and control images (16). With the same slice
prescription, calibration scans were acquired to provide an estimate
ofM0 (fully relaxed blood water magnetisation) (17). R2* was calcu-
lated from the dual-echo data, R2* = [ln(S1/S2)]/(TE2 – TE1), allowing
us to calculate the ΔR2* time course with respect to the mean R2*
of the initial baseline period of normoxia.
CBF was calculated using a standard single-compartment
model (17–19). We incorporated three corrections for alterations
of model parameters in hypoxia that are otherwise likely to bias
the CBF estimates.
(1) The shortening of T2* in hypoxia. The calculated ΔR2* time
course was used to dynamically correct the ASL signal. This
aims to account for the enhanced T2* decay of the perfusion
label, although this effect is expected to be small with the
short TE of 3 ms employed (20).
(2) The shortening of T1 of arterial blood. During the initial
normoxic baseline period, we assumed arterial blood
T1 = 1.664 s (21). During steady-state hypoxia (ﬁnal portion of
the hypoxic period), we assumed T1 for arterial blood=1.611 s,
based on the group mean level of blood oxygen desaturation
observed in this study and the dependence of T1 on oxygen-
ation reported in the literature (21). The change in R2* was
used as an index of oxygenation to estimate the arterial
blood T1 at each time point by linear interpolation between
1.611 s and 1.664 s.
(3) A reduced arterial arrival time with increasing blood ﬂow.
The expected increase in CBF with hypoxia is likely to result
in a decrease in the tissue arrival time. This is the time after
the labelling pulse at which the labelled spins are assumed
to have entered the parenchyma from the brain’s capillaries.
A decreased arrival time means that the labelled spins spend
less time relaxing at the T1 of blood and more time relaxing
at the T1 of brain parenchyma, assumed to be 1.165 s (22).
Tissue arrival times are expected to vary across the brain (23),
but we are unable to estimate this effect, having acquired
data only with a single post-label delay. We therefore
assume that, in normoxia, the label reaches the tissue at
1500 ms across the whole brain (TI2 for the ﬁrst slice
acquired). The estimate of the dependence of the tissue arrival
time on global CBF was based on the work of Ho et al. (24), in
which a 5-ms decrease in arrival time per 1% increase in CBF
was observed.
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As can be seen in equation (3) of ref. (18), which summarises
the signal model, the factor qP is dependent on CBF because of
the dependence of the arrival time on ﬂow and is dependent
on hypoxia through the changing blood T1. The expression was
therefore solved numerically to estimate CBF at each time point
using Matlab (The Mathworks Inc., Natick, MA, USA) and a tissue–
blood partition coefﬁcient of water (λ=0.9) (18).
A whole-brain T1-weighted (fast spoiled gradient recalled
echo, 1-mm3 voxels, TI/TR/TE = 450 ms/7.8 ms/3 ms) image was
used for registration. All data were registered to MNI space using
FLIRT [FSL, FMRIB – www.fmrib.ox.ac.uk/fsl (25)] and regional
data were extracted using anatomical regions deﬁned by the
MNI atlas, available in FSL (regions: frontal lobe, insula, occipital
lobe, parietal lobe, putamen, temporal lobe and thalamus).
Respiratory protocol
Inspired gas concentrations were controlled in the MR scanner
using dynamic end-tidal forcing (26). Subjects breathed through
a tight-ﬁtting facemask (Quadralite, Intersurgical, Wokingham,
Berkshire, UK). Gas partial pressures were measured using rapidly
responding gas analysers (Models CD-3A and S-3A; AEI Technologies,
Pittsburgh, PA, USA). Dynamic end-tidal forcing was performed
using custom software (BreatheDmx, Oxford University, written in
LabView, National Instruments, Newbury, Berkshire, UK), which
compares the measured end-tidal gases with the desired values
and then controls the gas delivery to the subjects on a breath-
by-breath basis to meet and maintain the desired end-tidal partial
pressure of each gas (26,27). Gas delivery from high-pressure gas
cylinders (BOC, Margam, Port Talbot, UK) was controlled with four
mass-ﬂow controllers (Model MFC 1559A, MKS Instruments,
Wilmington, MA, USA) for medical air, 100% O2, 10% O2/balance
nitrogen and 10% CO2/balance air, powered by two two-channel
power supplies (Model PR4000, MKS Instruments). An analogue-
to-digital data acquisition card (National Instruments Corp., Austin,
TX, USA) was used for the acquisition of the gas partial pressures
from the gas analysers (recorded at 500 Hz) and for the digitization
of the ﬂow direction from an MR-compatible ﬂow transducer
(VMM-400, Interface Associates, Laguna Niguel, CA, USA). Gases
ﬂowed continuously, passing through a mixing chamber placed
close to the volunteer to ensure adequate and fast mixing. The
inspirate was drawn from this continually ﬂowing gas stream.
The sampling port for the establishment of CO2 and O2 levels
was positioned on the port of the facemask. This design ensures
minimal delay in the delivery of an updated gas mixture and
minimal mixing of expired and inspired gases within the con-
straints of the end-tidal forcing system (26).
Resting partial pressures of end-tidal CO2 and O2 (PETCO2 and
PETO2, respectively) were established after the subject had
acclimatized to the experimental set-up but prior to the ASL
acquisition. The hypoxic protocol, based on that of Poulin et al. (8),
lasted 33 min and consisted of a 5-min baseline (normoxia),
20 min of hypoxia (target PETO2 = 50mmHg) and 8min of recovery
(normoxia) (see Fig. 1). The end-tidal forcing system aimed to
maintain PETCO2 at the subject’s resting value throughout.
Temporal response model
In order to quantify the magnitude and temporal dynamics of
the CBF and R2* responses, a temporal model similar to that of
Poulin et al. (8) was applied. We refer to CBF in the description
that follows; however, the same model was also applied to the
R2* time course. The hypoxic model parameters included: CBF
at baseline normoxia (CBFB); an exponential increase deﬁned
by the rate constant kH with the CBF increase beginning at a
delay δH after the onset of hypoxia, leading to a plateau CBF (CBFH)
during hypoxia; and, similarly, recovery during normoxia
beginning at a delay δR and described by an exponential rate con-
stant (kR) reaching a recovery CBF (CBFR). (See Fig. 1 for a schematic
description of these parameter deﬁnitions.) All parameters were
determined using nonlinear ﬁtting, and the 95% conﬁdence
intervals (95% CIs) of all the parameter ﬁts were estimated (Matlab)
as a reﬂection of the inﬂuence of noise in the data on the ﬁtted
parameters. The minimum values for the delay times δH and δR
were constrained to 20 s for CBF and to 0 s for R2*. There was an
inherent ﬁnite transition period of 20 s between the inspired
oxygen levels imposed by the function of the end-tidal forcing
system. We allowed our model to describe R2* changes without
delay because R2* would be expected to change as soon as the
blood oxygenation begins to transition. However, CBF is expected
to rise on the transition to hypoxia, for example, only after a
substantial drop in oxygenation has occurred, and the end-tidal
forcing system would not bring this about until after its 20-s
inherent transition period.
Before ﬁtting the time-series data to the model, in order to
improve the signal-to-noise ratio (SNR) in the CBF measurement,
registered individual subject data were averaged to produce a
group-averaged time course. The hypoxia time-series model
was applied to whole-brain grey matter and on a regional basis
using the MNI structural atlas to deﬁne the frontal lobe, insula,
occipital lobe, parietal lobe, putamen, temporal lobe and
thalamus. As a supplementary investigation, the model was also
used to characterise the hypoxic response in the whole-brain
grey matter of individual subjects.
Reactivity
Hypoxic reactivity was calculated on an individual subject basis
as the percentage change in CBF or the absolute change in R2*
from the last 5 min of the hypoxic period compared with the 5
min of baseline normoxia normalized by the absolute change
in PETO2.
Statistical analysis
Differences in physiological data (SpO2, PETO2, PETCO2, heart rate
and ventilation rate) between normoxia and hypoxia were tested
Figure 1. Schematic diagram of modelling parameters. This model was
used for both the cerebral blood ﬂow (CBF) and R2* time series but, for
descriptive purposes, we refer here to CBF only. CBFB is the CBF calcu-
lated during the baseline period, and CBFH and CBFR are the equilibrium
CBF values obtained during hypoxia and recovery, respectively. The rate
constants during the transition to hypoxia and back to normoxia during
the recovery are denoted by kH and kR, respectively, and these transitions
occur at delays of δH and δR after the gas mixtures are switched to the
hypoxic challenge or back to normoxia, respectively.
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using paired t-tests of the individual average data during
normoxic and the last 5 min of the hypoxic condition. Two-way
analysis of variance (ANOVA) was used to assess the effect of
region and subject on the regional reactivity for both the CBF
and R2* data.
RESULTS
All subjects tolerated the hypoxic challenges well. The hypoxic
challenge was stopped early in one subject because of a technical
difﬁculty and, as a result, the data from the ﬁnal ~10 min of this
session were excluded from the analysis.
During the hypoxic challenge, according to pulse oximetry,
subjects desaturated to an average SpO2 of 83%, with the
subject-averaged data reaching this level after 810 s. Group-
averaged total oxygen delivery at baseline was 15.1 mL/100 g/min
and, in hypoxia, was 14.7 mL/100 g/min, assuming that the
dissolved oxygen is negligible (13) and that the concentration of
haemoglobin (assumed to be 15 g/dL) does not change during
the challenge. A summary of the physiological data is shown in
Table 1. Sample CBFmaps are shown in Fig. 2, and group-averaged
end-tidal O2 and CO2 are shown in Fig. 3. Although the inclusion of
the dynamic changes in T1, R2* and tissue arrival times is expected
to reduce bias in the estimates for CBF in hypoxia, these
reﬁnements have the capacity to add noise in the calculated CBF
time series, for example, when noise is already present in the R2*
estimate as a result of headmotion. As a result of nonconvergence
of the numerical estimates of CBF, time-course data from three
regions from one subject and one from another were excluded
from the regional CBF estimates.
According to the model ﬁtting of the group-averaged data,
across grey matter, CBF increased from 76.1 mL/100 g/min
(95% CI: 75.5, 76.7) to 87.8 mL/100 g/min (95% CI: 86.7, 89.6),
with a rate constant of 0.0035 s–1 (95% CI: 0.0019, 0.0046) and
a delay of 185 s (95% CI: 132, 230). This corresponds to a 15.4%
increase in CBF. The parameters from the ﬁtting (and the 95%
CIs on these ﬁts showing the reliability or noise in the
parameter ﬁt) across the regions are given in Table 2. The CBF
and R2* time-course and model ﬁts for all grey matter are shown
in Fig. 4. The R2* response was more rapid than the CBF
response, with a rate constant of 0.0392 s–1 and a delay of 24 s
calculated for the transition to hypoxia (Table 3, Fig. 4).
Reactivity, summarized in Table 4, was calculated from the
average CBF from the last 5 min of hypoxia compared with
baseline normoxia. The two-way ANOVA examining the effects
Table 1. Summary of physiological measurements between baseline and hypoxic conditions (shown as mean± standard
deviation over subjects). The baseline average is across the entire 5-min baseline normoxia period and the hypoxic average is
the average across the last 5 min of the hypoxic period
Baseline Hypoxia p
SpO2 (%) 98.5
a 83.4 ± 6.8
Respiration rate (breaths/min) 13.2 ± 4.5 14.3 ± 3.7 0.05
Heart rate (beats/min) 66.6 ± 7.9 74.4 ± 8.7 <0.001
PETCO2 (mmHg) 41.2 ± 2.8 39.8 ± 2.5 <0.001
PETO2 (mmHg) 116.6 ± 4.4 52.0 ± 3.8 <0.001
PETCO2, partial pressure of end-tidal carbon dioxide; PETO2, partial pressure of end-tidal oxygen; SpO2, blood oxygen saturation.
p values are derived from a paired t-test comparing baseline normoxia with hypoxic hypoxia.
aAssumed from standard values.
Figure 2. Sample cerebral blood ﬂow (CBF) maps from one individual during normoxic baseline (a), hypoxic hypoxia (b) and normoxic recovery (c).
Each map is derived from 5 min of data and has been registered to MNI space. CBF is displayed in mL/100 g tissue/min.
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of subject and region on CBF did not show any differences across
regions, but did detect a subject effect ( p< 0.0001). For the R2*
data, both subject ( p< 0.0001) and region ( p= 0.02) were signif-
icant factors explaining the variance in regional reactivity.
DISCUSSION
We have described the dynamics of the CBF response to acute
hypoxic hypoxia in a cohort of healthy, young adults. Although
the CBF amplitude response to hypoxia has been investigated
previously using ASL (12,13), to our knowledge, this is the ﬁrst
time the temporal dynamics of the global and regional CBF
response have been quantiﬁed, and compared with a simulta-
neously acquired marker of cerebral blood oxygenation (R2*).
Across grey matter, the time-course model indicated that CBF
increased from 76.1 mL/100 g/min to 87.8 mL/100 g/min
(Table 2), showing a 15.4% increase in CBF during the hypoxic
challenge, which is consistent with the observed increases in
CBF during similar challenges (11–13). An exponential model
using a normoxic baseline and a single hypoxic condition has
been applied previously to describe the dynamics of the arterial
blood ﬂow response to a similar hypoxic challenge (target
PETO2 = 50 mmHg) using TCD to measure blood ﬂow in the
MCA (8). The study of Poulin et al. (8) used two rate constants
(one for the transition to hypoxia and another for the return to
normoxia) and a common delay term for the blood velocity
response for both the transition from normoxia to hypoxia and
the transition from hypoxia to normoxia. Here, we extend this
approach to include separate delay terms for the transition to
hypoxia and the return to normoxia. This additional model
ﬂexibility removes any assumptions of symmetry between
the blood ﬂow response to hypoxia and return to normoxia after
the hypoxic challenge. In the present study, the rate constant for
the CBF response to hypoxia across grey matter was 0.0035 s–1
and the delay for this response was 185 s (Table 2). The rate
constant and delay for the return to normoxia were 0.0069 s–1
and 20 s (not signiﬁcantly different from the 0-s delay as indicated
by the 95% CIs), respectively, both faster and shorter than the
transition to hypoxia, consistent with the observations in other
studies (8,13). After a 20-min hypoxic challenge, there is evidence
that blood ﬂow in the MCA remains mildly increased for
at least 5 min (28), which may indicate that a steady-state
condition is not reached within our 8-min observation period
during recovery.
Previously reported temporal parameters of ﬂow in the MCA
show a high degree of variability (8). We have presented a
group-averaged analysis in order to increase the SNR to assist
model ﬁtting to the data; however, uncertainty associated with
the ﬁtted parameters remains. For example, natural individual
heterogeneity may be a dominant source of rate constant
variability. The analysis performed on the group-averaged data
was also applied to individual data (Table S1). Although there
appear to be some outliers and some failures to estimate CBF,
these data illustrate potential inter-individual differences in the
CBF response to hypoxia. The rate constant for the return to
normoxia after the hypoxic challenge is more variable than
that of the response to hypoxia, both within and across regions
(see CIs in Table 2).
TCD studies estimating the temporal characteristics of the
blood ﬂow response to hypoxia have found higher rate
constants and shorter delays (i.e. a faster transition) than those
observed here (8,28) and qualitatively observed in a previous
ASL study of hypoxia [see ﬁgs 3–5 of ref. (13)]. Poulin et al. (8)
reported an average time constant of 79.6 s, equivalent to a rate
constant of 0.0126 s–1; however, on removing data from two
volunteers with measured time constants of less than 1 s, two
orders of magnitude less than the mean, the equivalent rate
constant is ~0.008 s–1, more similar to the values observed here.
Nevertheless, a difference between the dynamics estimated by
Poulin et al. (8) and the present experiment remains. As a result
of the experimental constraints of end-tidal forcing in the MR
environment, we chose a minimum 20-s transition period for
changes in target end-tidal values, which may affect the rate of
the CBF response. This could suggest a nonlinear relationship
between the speed of hypoxia onset and the rate of the CBF
response. Perhaps a faster hypoxia onset, as used by Poulin
et al. (8), stimulates a faster blood ﬂow response. Alternatively,
differences in the temporal SNR may result in longer delays
being estimated at lower SNR. TCD measures of CBF based on
bulk arterial blood velocity may differ from CBF based on the
ASL signal that arises from water that has entered the brain
tissue. Furthermore, it is common that, in TCD measurements,
the MCA is assumed not to change diameter; thus changes in
blood velocity are assumed to be proportional to changes in
blood ﬂow. However, a recent study using multiple imaging
modalities (TCD and phase-contrast MRI) has shown that the
MCA changes diameter after an acute (180 min) hypoxic
challenge and chronic hypoxic exposure (3), which could affect
the TCD estimates of dynamic changes in ﬂow.
Four reﬂexes are implicated in the blood ﬂow response to
hypoxia: (i) the hypoxic ventilatory response; (ii) the hypercapnic
ventilatory response; (iii) hypoxic vasodilation; and (iv) hypocapnic
vasoconstriction. These responses interact, increasing the system
complexity (1). Although there are multiple mechanisms of
vasodilation, adenosine is thought to be a main mediator of
hypoxic-induced vasodilation (1), and its concentration parallels
the increase in CBF during hypoxic exposure (29). Additional medi-
ators include potassium and calcium ions and nitric oxide (1). The
hypoxic ventilatory response is centrally mediated and modulated
by CO2, which is detected by both central and peripheral chemore-
ceptors (1). These interactions may be a cause of the delay of the
CBF response to the hypoxic stimulus. Cerebral autoregulation
has been shown to remain intact in acute hypoxia (30) and, more
recently (31), inconsistencies in reports have been attributed to
Figure 3. Group-averaged end-tidal O2 (black) and CO2 (grey).
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CO2 variation and have conﬁrmed that cerebral autoregulation is
also maintained during hypocapnic hypoxia.
We used the overall R2* as an indicator of changes in blood
oxygenation, as R2* is dependent on the concentration of
deoxyhaemoglobin in arterial and venous blood. This was then
used as an index of changes in T1 of arterial blood. As expected,
R2* responded rapidly to changes in the inspired oxygen levels,
conﬁrming that end-tidal forcing is effective in rapidly inducing
changes in arterial and venous oxygenation. The time-course
data of the R2* and CBF changes indicate consistency between
these two metrics during the hypoxic challenge, although there
are differences in the speed of response (Fig. 4). With the onset
of hypoxic hypoxia, R2* increases rapidly as a result of the
decrease in blood oxygenation, both arterial and venous.
Approximately 3 min (180 s, Table 2) after the onset of hypoxia
(time~ 480 s in Fig. 4), CBF begins to increase and, thereafter,
R2* decreases slightly (500–900 s, Fig. 4), which is consistent with
the increasing CBF resulting in increased cerebral venous
oxygenation. However, an increase in cerebral blood volume
associated with the increase in CBF would tend to oppose this ef-
fect, perhaps explaining the subsequent increase in R2* between
900 and 1500 s (Fig. 4). At the end of the hypoxic challenge, R2*
decreases rapidly, as arterial and venous oxygenation increase
towards normal (PETO2 ~ 110 mmHg). Again, the CBF response
is slower than the R2* response. After approximately 150 s, R2*
begins to increase slightly as the venous deoxyhaemoglobin
concentration rises, potentially as a result of the CBF decrease.
The use of dynamic end-tidal forcing enables the examination
of the effects of hypoxia with the advantage of being able to
perform well-controlled respiratory challenges. Despite the
end-tidal forcing system’s attempted control over PETCO2, there
was an average 1.3 mmHg decrease in PETCO2 during the
hypoxic challenge (Table 1). Hypocapnia decreases blood ﬂow
by 2–3%/mmHg (1); thus an underestimation of the hypoxic
CBF response of up to approximately 4% may be present.
The inclusion of the effects of changing T2*, arterial blood T1
and tissue arrival time had a substantial effect on the estimate
of CBF change with hypoxia. Without the inclusion of these
factors, CBF would be estimated to increase by approximately 9%,
in comparison with the 15% increase reported here with these
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Figure 4. Cerebral blood ﬂow (CBF) and R2* across whole-brain grey
matter. Quantiﬁed CBF and the CBF modelled response are shown in
light green and dark green, respectively. R2* over time and the modelled
response are shown in pink and red, respectively. The time-series data for
CBF and R2* were averaged into 11-s time bins for display purposes.
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factors included. The effect of hypoxia on shortening arterial blood
T1 and the assumed effect of the shortened arrival time had the
most substantial effect on the estimate of the CBF increase,
whereas the correction for shortened T2* played a minor role. T1
and the arrival time impact directly on the calculation of the
longitudinal magnetization. Without these corrections, the ﬂow
increase is underestimated, as the overall T1 decay of the label at
the point of signal acquisition is underestimated. The effect of
T2* was particularly small (~3.7% change in T2* between normoxia
and hypoxia) because of the short TE (3 ms) of our spiral acquisi-
tion, TE being deﬁned as the point at which the centre of k space
is traversed. There remains the possibility of un-modelled T2*
weighting of the CBF signal as the acquisition window naturally
extends beyond 3 ms. However, our focus on regional and
whole-brain analyses (low spatial frequency) means that our
results will be inﬂuenced most by data collected in the centre of
k space rather than the high-frequency data collected later in the
acquisition. Furthermore, the majority of the power of the signal
in k space is acquired within 6 ms of the excitation. If we assume
an effective time of signal acquisition of 6ms, the subsequent error
in the reported CBF estimate would be less than 1%.
Using nuclear medicine imaging methods, others (2,10,11)
have detected regional differences in the magnitude of the
CBF response to hypoxia. However, the regions that show
increased blood ﬂow during hypoxia differed between these
studies. Binks et al. (11) observed different responses regionally,
and attributed these differences to differing phylogenetic ages
of the regions, speciﬁcally that ‘older’ brain regions have an
increased CBF response compared with ‘newer’ regions. Pagani
et al. (10) reported a greater hypoxic CBF response in the sensory
motor cortex, anterior cingulate cortex, prefrontal cortex, basal
ganglia and right temporal lobe. Some of these regions are com-
ponents of attentional networks, and Pagani et al. (10) suggested
that, because attention is a basic, energy-consuming process,
these networks are protected in acute hypoxia. The resolution
of the discrepancies in differences in the CBF response is further
confounded by the observation that arteries feeding the brain
have different sensitivities to hypoxia (7). Nevertheless, regional
differences in the CBF response to hypoxia have interesting
implications in terms of cerebrovascular physiology and vulnera-
bility to hypoxic damage. Therefore, in addition to examining the
hypoxic response across the entire brain, we also analysed the
hypoxic response regionally. As a result of limited brain
coverage, and with the need in mind to perform spatial signal
averaging to maintain signal-to-noise for model ﬁtting, we
restricted our regional analysis to seven broad regions. We did
not detect regional differences in CBF reactivity. However,
regional differences in R2* reactivity were signiﬁcant. Subject
was a signiﬁcant factor for both CBF and R2* reactivity, but the
inter-subject differences did not appear to be explained by the
small differences in the level of PETO2 reached (data not shown).
Therefore, it appears that individuals may have notably different
levels of overall hypoxic reactivity. This inter-subject heterogene-
ity reduces our ability to detect inter-regional differences in
reactivity to hypoxia across the group, but may also be important
in determining the effects on an individual of a hypoxic event.
CONCLUSIONS
In this study, we quantiﬁed the dynamic CBF response to
hypoxia during an acute (20 min) hypoxic challenge. We
characterised both the magnitude and temporal characteristics
of the CBF response across all grey matter and on a regional
basis, and found that, across grey matter, CBF increased by
approximately 15% at mean PETO2 = 52 mmHg. In addition, we
used R2* as a simultaneous marker of local blood oxygenation.
In this healthy population, the CBF response to hypoxia was
relatively slow, with a delay to onset of approximately 3 min and
a time constant of approximately 4.5 min. In contrast, the CBF
response on the return to normoxia from hypoxia was more rapid.
The blood oxygenation response was much more rapid and was
contemporaneous with the onset of the hypoxic challenge. Broad
regional differences in the CBF response to hypoxia were not
detected. However, individual heterogeneity may have a substan-
tial role in determining the CBF response to hypoxia.
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